LeMaitre Vascular, Inc. (LMAT): Price and Financial Metrics


LeMaitre Vascular, Inc. (LMAT): $53.55

0.43 (+0.81%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LMAT Stock Summary

  • Price to trailing twelve month operating cash flow for LMAT is currently 31.33, higher than 83.32% of US stocks with positive operating cash flow.
  • LMAT's price/sales ratio is 8.43; that's higher than the P/S ratio of 79.08% of US stocks.
  • With a year-over-year growth in debt of 248.63%, Lemaitre Vascular Inc's debt growth rate surpasses 94.9% of about US stocks.
  • Stocks that are quantitatively similar to LMAT, based on their financial statements, market capitalization, and price volatility, are ATRI, ALOT, CHFS, BRKS, and VAPO.
  • Visit LMAT's SEC page to see the company's official filings. To visit the company's web site, go to www.lemaitre.com.

LMAT Stock Price Chart Interactive Chart >

Price chart for LMAT

LMAT Price/Volume Stats

Current price $53.55 52-week high $54.96
Prev. close $53.12 52-week low $23.40
Day low $52.84 Volume 104,100
Day high $54.46 Avg. volume 123,000
50-day MA $48.75 Dividend yield 0.83%
200-day MA $38.60 Market Cap 1.10B

LeMaitre Vascular, Inc. (LMAT) Company Bio


LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease. The company was founded in 1983 and is based in Burlington, Massachusetts.

LMAT Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$53.55$42.33 -15%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Lemaitre Vascular Inc. To summarize, we found that Lemaitre Vascular Inc ranked in the 51th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Lemaitre Vascular Inc ended up being:

  • The business' balance sheet reveals debt to be 5% of the company's capital (with equity being the remaining amount). Approximately merely 18.13% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than merely 0% of stocks in its sector (Healthcare).


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-17%
1%-16%
2%-15%
3%-15%
4%-14%
5%-13%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as LMAT, try ITGR, PBH, IQV, SYNH, and UNH.


LMAT Latest News Stream


Event/Time News Detail
Loading, please wait...

LMAT Latest Social Stream


Loading social stream, please wait...

View Full LMAT Social Stream

Latest LMAT News From Around the Web

Below are the latest news stories about Lemaitre Vascular Inc that investors may wish to consider to help them evaluate LMAT as an investment opportunity.

Thermo Fisher (TMO) Rides on End Markets as Pandemic Rages On

In diagnostics and healthcare, Thermo Fisher (TMO) is experiencing high demand for COVID-19 testing and manages to record 200% growth.

Yahoo | April 13, 2021

Medtronic's (MDT) GI Genius Module Gets FDA De Novo Clearance

Medtronic's (MDT) GI Genius Module is the only commercially available computer-aided detection system which uses artificial intelligence to identify colorectal polyploid.

Yahoo | April 13, 2021

New Strong Buy Stocks for April 8th

New Strong Buy Stocks for April 8th

Yahoo | April 8, 2021

Can You Imagine How Jubilant LeMaitre Vascular's (NASDAQ:LMAT) Shareholders Feel About Its 221% Share Price Gain?

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you...

Yahoo | April 2, 2021

LeMaitre (LMAT) Stock Jumps 5.2%: Will It Continue to Soar?

LeMaitre (LMAT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Yahoo | March 18, 2021

Read More 'LMAT' Stories Here

LMAT Price Returns

1-mo 17.05%
3-mo 18.15%
6-mo 63.95%
1-year 96.23%
3-year 42.58%
5-year 237.66%
YTD 32.53%
2020 14.09%
2019 53.77%
2018 -25.13%
2017 26.58%
2016 48.46%

LMAT Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full LMAT Dividend History

Continue Researching LMAT

Here are a few links from around the web to help you further your research on Lemaitre Vascular Inc's stock as an investment opportunity:

Lemaitre Vascular Inc (LMAT) Stock Price | Nasdaq
Lemaitre Vascular Inc (LMAT) Stock Quote, History and News - Yahoo Finance
Lemaitre Vascular Inc (LMAT) Stock Price and Basic Information | MarketWatch

Page generated in 1.0898 seconds.